Stay updated with the latest research and news from Double-Strand LLC.
This academic article introduces a noninvasive method for characterizing Alzheimer's disease (AD) by analyzing cell-free messenger RNA (cf-mRNA) found in blood plasma.
Posted on: June 16, 2025
Read More
This Nature Communications article presents a groundbreaking study on cell-free RNA (cfRNA) as a novel biomarker for cancer detection. The researchers comprehensively characterized cfRNA in both cancer and non-cancer patients, leading to the discovery of so-called "dark channel biomarker" (DCB) genes.
Posted on: June 16, 2025
Read More
A landmark 1999 study by Kopreski et al. published in Clinical Cancer Research demonstrated the detection of tumor messenger RNA in the serum of patients with malignant melanoma. The researchers successfully demonstrated the presence of amplifiable human mRNA, specifically tyrosinase mRNA, in the serum of melanoma patients, a significant finding given the presumed instability of mRNA in blood.
Posted on: June 16, 2025
Read More